http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 14 Jul 2026 16:06:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++/26768294.html si-local-file:///var/storage/secattach/20260714/26768294.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++/26768294.html Tue, 14 Jul 2026 16:06:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++/26768294.html si-local-file:///var/storage/secattach/20260714/26768294.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++/26768294.html Tue, 14 Jul 2026 16:06:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jul+08++Filed+by%3A+Manhede+Joseph/26748637.html si-local-file:///var/storage/secattach/20260708/26748637.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jul+08++Filed+by%3A+Manhede+Joseph/26748637.html Wed, 08 Jul 2026 19:05:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jul+08++Filed+by%3A+Manhede+Joseph/26748637.html si-local-file:///var/storage/secattach/20260708/26748637.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jul+08++Filed+by%3A+Manhede+Joseph/26748637.html Wed, 08 Jul 2026 19:05:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Malik+Fady+Ibraham/26741516.html si-local-file:///var/storage/secattach/20260707/26741516.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Malik+Fady+Ibraham/26741516.html Tue, 07 Jul 2026 15:13:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Malik+Fady+Ibraham/26741516.html si-local-file:///var/storage/secattach/20260707/26741516.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Malik+Fady+Ibraham/26741516.html Tue, 07 Jul 2026 15:13:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+BOESS+CARSTEN/26737103.html si-local-file:///var/storage/secattach/20260706/26737103.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+BOESS+CARSTEN/26737103.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+BOESS+CARSTEN/26737103.html si-local-file:///var/storage/secattach/20260706/26737103.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+BOESS+CARSTEN/26737103.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+SOUTHWELL+DAVID+P/26737105.html si-local-file:///var/storage/secattach/20260706/26737105.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+SOUTHWELL+DAVID+P/26737105.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+SOUTHWELL+DAVID+P/26737105.html si-local-file:///var/storage/secattach/20260706/26737105.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+SOUTHWELL+DAVID+P/26737105.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Fong+Peter/26737106.html si-local-file:///var/storage/secattach/20260706/26737106.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Fong+Peter/26737106.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Fong+Peter/26737106.html si-local-file:///var/storage/secattach/20260706/26737106.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Fong+Peter/26737106.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Malik+Fady+Ibraham/26737108.html si-local-file:///var/storage/secattach/20260706/26737108.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Malik+Fady+Ibraham/26737108.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Malik+Fady+Ibraham/26737108.html si-local-file:///var/storage/secattach/20260706/26737108.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Malik+Fady+Ibraham/26737108.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Dolsten+Mikael/26737110.html si-local-file:///var/storage/secattach/20260706/26737110.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Dolsten+Mikael/26737110.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Dolsten+Mikael/26737110.html si-local-file:///var/storage/secattach/20260706/26737110.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+Dolsten+Mikael/26737110.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+WONG+RODERICK/26737111.html si-local-file:///var/storage/secattach/20260706/26737111.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+WONG+RODERICK/26737111.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+WONG+RODERICK/26737111.html si-local-file:///var/storage/secattach/20260706/26737111.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+18++Filed+by%3A+WONG+RODERICK/26737111.html Mon, 06 Jul 2026 20:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+24/26714826.html si-local-file:///var/storage/secattach/20260630/26714826.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+24/26714826.html Tue, 30 Jun 2026 17:16:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+24/26714826.html si-local-file:///var/storage/secattach/20260630/26714826.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+24/26714826.html Tue, 30 Jun 2026 17:16:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+10/26638209.html si-local-file:///var/storage/secattach/20260612/26638209.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+10/26638209.html Fri, 12 Jun 2026 07:11:00 -0400 O.00056691 RCKT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+10/26638209.html si-local-file:///var/storage/secattach/20260612/26638209.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Jun+10/26638209.html Fri, 12 Jun 2026 07:11:00 -0400 O.00056691 RCKT http://www.streetinsider.com/Corporate+News/Rocket+Pharmaceuticals+completes+%24180+million+priority+review+voucher+sale/26638155.html <p>Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) completed the sale of its Rare Pediatric Disease Priority Review Voucher for $180 million in gross proceeds, according to a company statement.</p><p>The FDA granted the voucher in March 2026 following approval of KRESLADI, Rocket's gene therapy for severe leukocyte adhesion deficiency-I, a rare primary immunodeficiency condition.</p><p>The biotechnology company reported cash, cash equivalents and investments of $144.4 million as of March 31, 2026. The voucher sale proceeds increased the company's pro forma cash position to approximately $322.6 million, which Rocket expects will fund operations through the second quarter of 2028.</p><p>The priority review voucher allows pharmaceutical companies http://www.streetinsider.com/Corporate+News/Rocket+Pharmaceuticals+completes+%24180+million+priority+review+voucher+sale/26638155.html Fri, 12 Jun 2026 07:01:08 -0400 RCKT http://www.streetinsider.com/Press+Releases/Rocket+Pharmaceuticals%C2%A0Announces+Closing+of+Sale+of%C2%A0Rare+Pediatric+Disease+Priority+Review+Voucher+for+%24180+Million/26638125.html <p> CRANBURY, N.J.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Frocketpharma.com%2F&amp;esheet=54552043&amp;newsitemid=20260612407717&amp;lan=en-US&amp;anchor=Rocket+Pharmaceuticals%2C+Inc.&amp;index=1&amp;md5=659819ff9e155a692b2d72da9305f5f3" shape="rect">Rocket Pharmaceuticals, Inc.</a> (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $180 million. </p><p> The Rare Pediatric Disease Priority Review Voucher was granted by the FDA in March 2026 in connection with the approval of KRESLADI™, Rocket’s gene therapy for severe leukocyte adhesion deficiency-I (LAD-I), a rare and life-threatening primary immunodeficiency. </p><p> As previously reported, before the PRV sale Rocket http://www.streetinsider.com/Press+Releases/Rocket+Pharmaceuticals%C2%A0Announces+Closing+of+Sale+of%C2%A0Rare+Pediatric+Disease+Priority+Review+Voucher+for+%24180+Million/26638125.html Fri, 12 Jun 2026 07:00:00 -0400 O.00056691 RCKT http://www.streetinsider.com/Press+Releases/Rocket+Pharmaceuticals%C2%A0Announces+Closing+of+Sale+of%C2%A0Rare+Pediatric+Disease+Priority+Review+Voucher+for+%24180+Million/26638125.html <p> CRANBURY, N.J.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Frocketpharma.com%2F&amp;esheet=54552043&amp;newsitemid=20260612407717&amp;lan=en-US&amp;anchor=Rocket+Pharmaceuticals%2C+Inc.&amp;index=1&amp;md5=659819ff9e155a692b2d72da9305f5f3" shape="rect">Rocket Pharmaceuticals, Inc.</a> (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $180 million. </p><p> The Rare Pediatric Disease Priority Review Voucher was granted by the FDA in March 2026 in connection with the approval of KRESLADI™, Rocket’s gene therapy for severe leukocyte adhesion deficiency-I (LAD-I), a rare and life-threatening primary immunodeficiency. </p><p> As previously reported, before the PRV sale Rocket http://www.streetinsider.com/Press+Releases/Rocket+Pharmaceuticals%C2%A0Announces+Closing+of+Sale+of%C2%A0Rare+Pediatric+Disease+Priority+Review+Voucher+for+%24180+Million/26638125.html Fri, 12 Jun 2026 07:00:00 -0400 O.00056691 RCKT